Showing results (71-80 of 114) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2015
A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell TransplantationSally Arai, Joseph Pidala, Iskra Pusic, et al.
Blood Advances|January 4, 2018
Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinibTracy E Wiczer, Lauren B Levine, Jessica Brumbaugh, et al.
Blood Advances|February 12, 2020
Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCLRakesh Awasthi, Lida Pacaud, Edward Waldron, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 1, 2024
Brentuximab Vedotin Plus Ibrutinib in Relapsed and Refractory Hodgkin LymphomaMatthew Mei, Ni-Chun Tsai, Joycelynne Palmer, et al.
Frontiers in Oncology|October 2, 2023
Impact of circulating lymphoma cells at diagnosis on outcomes in patients with Waldenstrom macroglobulinemiaAnsel Nalin, Qiuhong Zhao, Timothy Voorhees, et al.
The New England Journal of Medicine|December 4, 2018
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell LymphomaStephen J Schuster, Michael R Bishop, Constantine S Tam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2022
Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 StudyMichael Wang, Javier Munoz, Andre Goy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 11, 2015
Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT)Yvonne A Efebera, Susan Geyer, Leslie Andritsos, et al.
Research Square|February 6, 2026
The Anxious Bipolar Phenotype: Clinical Complexity and Treatment ResistanceBalwinder Singh, Ada Man-Choi Ho, Brandon Coombes, et al.
The New England Journal of Medicine|April 4, 2020
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell LymphomaMichael Wang, Javier Munoz, Andre Goy, et al.
Pageof 12